4/A

PRIMARY DOCUMENT

Company: FILANA THERAPEUTICS, INC.
Filed: May 19, 2011
Period of Report: May 19, 2011
Accession Number: 0001245261-11-000013

View Document ↗ View on SEC.gov ↗